Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Insecticide danger to bees addressed
European report looks at chemical risk

A report by the European Food Safety Authority (EFSA) has deemed the world's most widely-used insecticide an unacceptable danger to bees.

The report was demanded by the European commission in April, following two major studies earlier in the spring that found a link between the use of neonicotinoids and the UK's decline in bees. Further studies have been produced since.

Bees and other pollinators are critical to one-third of all food, therefore, the report examined the risk posed by the chemicals, including the widely-used insecticide, imidacloprid.

Working together with experts from across Europe, EFSA's report concluded that the use of imidacloprid would only be considered acceptable on crops that honeybees are not attracted to.

EFSA added that it found a widespread lack of information in many areas, earlier stating that current "simplistic" regulations contained "major weaknesses".

Andrew Pendleton, of Friends of the Earth, said: "This is a major turning point in the battle to save our bees. EFSA have sounded the death knell for one of the chemicals most frequently linked to bee decline and cast serious doubt over the safety of the whole neonicotinoid family."

However, a spokesperson for the company that produces imidaclopid, said: "The company is ready to work with the European commission and member states to address the perceived data gaps.

"We believe it is very important that any political decision relating to registrations of neonicotinoid-containing products should be based on clear, scientific evidence of adverse effects."

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.